Literature DB >> 6092097

Inhibition of the cardiac response to sympathetic nerve stimulation by opioid peptides and its potentiation by morphine and methadone.

F Ledda, L Mantelli, V Corti, R Fantozzi.   

Abstract

[D-Ala2,D-Leu5]enkephalin (1-10 microM) and [Met5]enkephalin-Arg-Phe (1-10 microM) produced concentration-dependent inhibition of the cardiac response to field stimulation of the adrenergic nerve terminals in preparations pretreated with peptidase inhibitors (captopril 10 microM, bestatin 10 microM, thiorphan 0.3 microM and L-leucyl-L-leucine 2 mM). The inhibitory response to the opioid agonists was evident in preparations superfused with solutions containing 1.8 mM calcium, but not in those containing 3.6 mM calcium. Moreover the inhibition was antagonized by naloxone 10 microM. [D-Ala2,Met5]enkephalinamide (1-3 microM) and beta-endorphin (1-3 microM) did not significantly affect the sympathetic response. The cardiac response to sympathetic stimulation was not inhibited but, on the contrary, was potentiated by morphine (3-10 microM) and methadone (3-10 microM). It is suggested that the depressant effect of the opioid peptides was due to stimulation of presynaptic inhibitory opiate receptors on adrenergic nerve terminals of the heart, and that the potentiation of the sympathetic response by morphine and methadone was probably attributable to an unspecific inhibitory effect on the neuronal uptake of noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092097     DOI: 10.1016/0014-2999(84)90565-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Peripheral sympatho-inhibitory cardiovascular effects of opioid peptides in anaesthetized rabbits.

Authors:  B Szabo; L Hedler; C Schurr; K Starke
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

2.  The sympathetic axons innervating the sinus node of the rabbit possess presynaptic opioid kappa- but not mu- or delta-receptors.

Authors:  K Starke; E Schöffel; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

3.  Different effects of prostaglandins on adrenergic neurotransmission in atrial and ventricular preparations.

Authors:  L Mantelli; S Amerini; F Ledda
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

4.  Influence of the optical isomers (+)- and (-)-naloxone on beating frequency, contractile force and action potentials of guinea-pig isolated cardiac preparations.

Authors:  H Brasch
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

5.  On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.

Authors:  H Fuder; M Buder; H D Riers; G Rothacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

Review 6.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

7.  Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.

Authors:  Phu N Tran; Jiansong Sheng; Aaron L Randolph; Claudia Alvarez Baron; Nicolas Thiebaud; Ming Ren; Min Wu; Lars Johannesen; Donna A Volpe; Dakshesh Patel; Ksenia Blinova; David G Strauss; Wendy W Wu
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.